Long-term efficacy and safety of radiofrequency renal denervation

Media formats available:

Hemodynamic valve deterioration in transcatheter aortic valves vs. surgical aortic valves
Hemodynamic valve deterioration in transcatheter aortic valves vs. surgical aortic valves
ACC.22
Hemodynamic valve deterioration in transcatheter aortic valves vs. surgical aortic valves
- Megan Coylewright, MD
A first clinical trial testing the use of an H₂S donor after heart attack
A first clinical trial testing the use of an H₂S donor after heart attack
ACC.22
A first clinical trial testing the use of an H₂S donor after heart attack
- Marie-Sophie de Koning, MD
Reductions in LVOT gradients, NYHA class and NT-proBNP with cardiac myosin inhibitor in HCM
Reductions in LVOT gradients, NYHA class and NT-proBNP with cardiac myosin inhibitor in HCM
ACC.22
Reductions in LVOT gradients, NYHA class and NT-proBNP with cardiac myosin inhibitor in HCM
- Florian Rader, MD
PCSK9i reduces plaque burden in coronary arteries
PCSK9i reduces plaque burden in coronary arteries
ACC.22
PCSK9i reduces plaque burden in coronary arteries
- Prof. Lorenz Räber, MD, PhD

PACE-CME